Literature DB >> 6126286

Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.

G Holdstock, B F Chastenay, E L Krawitt.   

Abstract

Suppressor T cell activity was measured in 18 patients with Crohn's disease and 20 controls, using two different functional assays. The effects of sulphasalazine and its metabolites on in vitro suppressor cell activity were also studied. The activity of a Con A-induced suppressor cell system in patients with Crohn's disease did not differ from that of controls, suggesting that the previously reported abnormalities are a secondary phenomenon. Furthermore, the activity of a non-induced suppressor T cell system was also normal in these patients. There was no evidence either in vivo or in vitro to suggest that sulphasalazine exerts its beneficial action by an effect on this aspect of immunoregulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126286      PMCID: PMC1536615     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Immunological aspects of inflammatory bowel disease.

Authors:  P J Whorwell; R Wright
Journal:  Clin Gastroenterol       Date:  1976-05

2.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

3.  Concanavalin A-induced suppressor cell activity opposing effects of hydrocortisone.

Authors:  W Knapp; B Posch
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

4.  Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.

Authors:  B West; R Lendrum; M J Hill; G Walker
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

5.  Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Authors:  P Sharon; M Ligumsky; D Rachmilewitz; U Zor
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

6.  Effects of sulfasalazine on selected lymphocyte subpopulations in vivo and in vitro.

Authors:  W R Thayer; C Charland; C E Field
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

7.  The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

8.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

9.  Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI).

Authors:  W R Best; J M Becktel; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  7 in total

1.  Antigen induced suppression in peripheral blood and lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  H R Dalton; P Hoang; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

2.  Immune status in healthy relatives of patients with familial Crohn's disease.

Authors:  A Van Gossum; E Dupont; L Schandene; M Cremer; J Wybran
Journal:  Dig Dis Sci       Date:  1988-08       Impact factor: 3.199

3.  Immunological studies on Crohn's disease. V. Enumeration of circulating lymphocytes subsets using monoclonal antibodies.

Authors:  N Okabe; K Fujita; M Yamasaki; T Yao; S Tsuru
Journal:  Gastroenterol Jpn       Date:  1985-10

4.  Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.

Authors:  G Sieber; F Herrmann; M Zeitz; H Teichmann; H Rühl
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

5.  T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren; O Sjöberg
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

6.  [Effect of intestinal resection on the behavior of mononuclear subpopulations in Crohn disease].

Authors:  R Decker; M Betzler; A Scherer; U Abel; H P Geisen
Journal:  Langenbecks Arch Chir       Date:  1986

7.  Mechanism of action of 5-arninosalicylic acid.

Authors:  N A Punchard; S M Greenfield; R P Thompson
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.